Cargando…
Timing and localization of myasthenia gravis‐related gene expression
Myasthenia gravis (MG) is an acquired autoimmune disorder caused by autoantibodies binding acetylcholine receptors (AChR), muscle‐specific kinase (MuSK), agrin or low‐density lipoprotein receptor‐related protein 4 (Lrp4). These autoantibodies inhibit neuromuscular transmission by blocking the functi...
Autores principales: | Vergoossen, Dana L. E., Keo, Arlin, Mahfouz, Ahmed, Huijbers, Maartje G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457065/ https://www.ncbi.nlm.nih.gov/pubmed/34228850 http://dx.doi.org/10.1111/ejn.15382 |
Ejemplares similares
-
Cingulate networks associated with gray matter loss in Parkinson's disease show high expression of cholinergic genes in the healthy brain
por: Keo, Arlin, et al.
Publicado: (2021) -
MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity
por: Huijbers, Maartje G., et al.
Publicado: (2019) -
Treating muscle-specific kinase myasthenia gravis from the inside out
por: Huijbers, Maartje G., et al.
Publicado: (2019) -
Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis
por: Vergoossen, Dana L. E., et al.
Publicado: (2021) -
Myasthenia Gravis
Publicado: (1905)